Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Sees Significant Growth in Short Interest

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 16,900 shares, a growth of 16,800.0% from the November 15th total of 100 shares. Based on an average daily volume of 46,600 shares, the short-interest ratio is currently 0.4 days.

Awakn Life Sciences Stock Performance

Shares of AWKNF opened at $0.08 on Friday. The business has a fifty day moving average of $0.08 and a 200 day moving average of $0.08. Awakn Life Sciences has a 52-week low of $0.05 and a 52-week high of $0.19.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.